Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Adenocarcinoma and EPHB4[original query] |
---|
Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012 May 7 (5): 856-65. Pietanza M Catherine, Gadgeel Shirish M, Dowlati Afshin, Lynch Thomas J, Salgia Ravi, Rowland Kendrith M, Wertheim Michael S, Price Katharine A, Riely Gregory J, Azzoli Christopher G, Miller Vincent A, Krug Lee M, Kris Mark G, Beumer Jan H, Tonda Margaret, Mitchell Ben, Rizvi Naiyer |
Genomic alterations of ground-glass nodular lung adenocarcinoma. Scientific reports 2018 5 8 (1): 7691. Lee Hyun, Joung Je-Gun, Shin Hyun-Tae, Kim Duk-Hwan, Kim Yujin, Kim Hojoong, Kwon O Jung, Shim Young Mog, Lee Ho Yun, Lee Kyung Soo, Choi Yoon-La, Park Woong-Yang, Hayes D Neil, Um Sang-W |
The expressions of EphB4 and ephrinB2 in lung adenocarcinomas: a high level of the EphB4 protein is associated with lymph node metastasis. International journal of clinical and experimental pathology 2020 1 12 (9): 3447-3452. Li Ji, Sun Yuejun, Wang Xiaoxia, Wang Jiandong, Zhu Yeha |
EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer. International journal of molecular sciences 2021 8 22 (16): . Nanamiya Ren, Saito-Koyama Ryoko, Miki Yasuhiro, Inoue Chihiro, Asavasupreechar Teeranut, Abe Jiro, Sato Ikuro, Sasano Hirono |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: